Adoptive cellular immunotherapy of cancer in mice using allogeneic T-cells

Annals of Surgical Oncology

Volumn 3, Issue 1, 1996, Pages 67-73

  Bartels, Christopher J ^a   Rosenberg, Steven A ^a   Yang, James C ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Adoptive immunotherapy; T cell

Indexed keywords

ADENOCARCINOMA; ADOPTIVE IMMUNOTHERAPY; ANIMAL; ARTICLE; C57BL MOUSE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; GENE; GENETICS; LUNG TUMOR; MOUSE; PATHOLOGY; PHENOTYPE; TUMOR ASSOCIATED LEUKOCYTE;

ADENOCARCINOMA; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; GENES, MHC CLASS I; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED C57BL; PHENOTYPE;

EID: 0029688251     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02409054     Document Type: Article

References (16)

1. Rosenberg SA, Packard BS, Aebersold PM, et al. Special report. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with malignant melanoma. A preliminary report. N Engl J Med 1988;319:1676.
2. Rosenberg SA, Yannelli JR, Yang JC, et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and Interleukin 2. J Natl Cancer Inst 1994;86:1159-66.
3. Crowley NJ, Slingluff CL Jr, Darrow TL, Seigier HF. Generation of human autologous melanoma-specific cytotoxic T-cells using HLA-A2 matched allogeneic melanomas. Cancer Res 1990;50:492-8.
4. Darrow TL, Slingluff CL Jr, Seigier HF. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T-lymphocytes. Evidence for shared tumor antigens. J Immunol 1989;142:3329-35.
5. Hom SS, Topalian SL, Simonis T, Mancini M, Rosenberg SA. Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen recognition. J Immunother 1991;10:153-64.
6. Kawakami Y, Zakut R, Topalian SL, Stötter H, Rosenberg SA. Shared human melanoma antigens. J Immunol 1992;148: 638-43.
7. Kawakami Y, Eliyahu S, Delgado C, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-9.
8. Topalian SL, Hom SS, Kawakami Y, et al. Recognition of shared melanoma antigens by human tumor infiltrating lymphocytes. J Immunother 1992;12:203-6.
9. Traversari C, van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytotolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992;176:1453-7.
10. Van Der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytotoxic T lymphocytes on human melanoma. Science 1991;25:1643-7.
11. Brichard V, Van Pel A, Wölfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes. J Exp Med 1993;178:489-95.
12. Lee TD. Distribution of HLA antigens in North American Caucasians, North American Blacks and Orientals. In: Lee J, ed. The HLA system. New York: Springer-Verlag, 1990: 141-78.
13. Yang JC, Perry-Lalley D, Rosenberg SA. An improved method for growing murine tumor-infiltrating lymphocytes with in vivo antitumor activity. J Biol Resp Mod 1990;9:149.
14. Schwartzentruber DJ. In vitro predictors of clinical response in patients receiving interleukin-2-based immunotherapy. Curr Opin Oncol 1993;5:1055-8.
15. NIH rodents 1982 catalogue. NIH publication no. 83-606. Bethesda, MD: Department of Health and Human Services, National Institutes of Health, 1982:31,46.
16. Yonemoto RH, Terasaki PI. Cancer immunotherapy with HLA-compatible thoracic duct lymphocyte transplantation. A preliminary report. Cancer 1972;30:6.1438-43.